Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
ADVAIR DISKUS
Generic name / active ingredient
fluticasone propionate and salmeterol
Dosage-form class
Dry-powder inhaler(DISKUS); two-ingredient preloaded blisters
Route
Oral inhalation
Record reviewed
2026-08-17

Copy from the pack in hand

Source-linked reading points

  • Check the brand, both ingredients, the complete two-number marking per inhalation, the DISKUS dry-powder device and target market together. Do not read only one number or treat a package marking as a web-calculated daily inhalation count.
  • This label describes ADVAIR DISKUS as an oral-inhalation powder. A similar name, one shared ingredient or the fact that both are inhalers does not establish that another aerosol, nebulised solution, inhalation capsule or device can be self-substituted.
  • The label distinguishes maintenance treatment from immediate relief of acute bronchospasm. Sudden or worsening breathing difficulty, cough or wheeze needs timely action through local emergency services and an existing care plan, not repeated self-use, device stacking or borrowing another person's medicine from a webpage.
  • All current inhalers, prescription medicines, OTC products, supplements and herbs should be reviewed with the actual device by a pharmacist or clinician. Sharing one ingredient in a combination product does not mean two products can be self-combined, alternated or substituted.

Reviewed presentation examples — compare every field

  • 100/50 mcg per labelled inhalation; one DISKUS inhaler (60 blisters)NDC 0173-0695-00
  • 250/50 mcg per labelled inhalation; one DISKUS inhaler (60 blisters)NDC 0173-0696-00
  • 500/50 mcg per labelled inhalation; one DISKUS inhaler (60 blisters)NDC 0173-0697-00

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-17
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image